NABP Announces Walgreens Joining Pulse Platform
Walgreens (WBA) has joined Pulse by NABP™, a digital platform designed to enhance visibility in the drug supply chain and protect patients from counterfeit medications. This move will assist Walgreens with Drug Supply Chain Security Act (DSCSA) compliance and ensure its prescription medication suppliers are properly licensed.
The DSCSA, enacted in 2013, aims to improve pharmaceutical supply chain safety and prevent harmful drugs from entering the market. Pulse will help Walgreens verify that only legitimate and authorized trading partners provide medications to its patients.
John Colaizzi, VP of pharmacy practice at Walgreens, emphasized the company's commitment to patient safety. NABP is initially rolling out Pulse to select supply chain users, with plans to offer free registration to all prescription drug supply chain members to facilitate DSCSA-required interoperability.
Walgreens (WBA) ha aderito a Pulse by NABP™, una piattaforma digitale progettata per migliorare la visibilità nella catena di approvvigionamento dei farmaci e proteggere i pazienti da medicinali contraffatti. Questa mossa aiuterà Walgreens a garantire la conformità al Drug Supply Chain Security Act (DSCSA) e a verificare che i fornitori di farmaci da prescrizione siano adeguatamente autorizzati.
Il DSCSA, entrato in vigore nel 2013, mira a migliorare la sicurezza della catena di approvvigionamento farmaceutico e a prevenire che farmaci pericolosi entrino nel mercato. Pulse aiuterà Walgreens a verificare che solo partner commerciali legittimi e autorizzati forniscano medicinali ai suoi pazienti.
John Colaizzi, VP della pratica farmaceutica di Walgreens, ha sottolineato l'impegno dell'azienda per la sicurezza dei pazienti. NABP sta lanciando inizialmente Pulse a utenti selezionati della catena di approvvigionamento, con piani per offrire registrazione gratuita a tutti i membri della catena di approvvigionamento dei farmaci da prescrizione per facilitare l'interoperabilità richiesta dal DSCSA.
Walgreens (WBA) se ha unido a Pulse by NABP™, una plataforma digital diseñada para mejorar la visibilidad en la cadena de suministro de medicamentos y proteger a los pacientes de medicamentos falsificados. Este movimiento ayudará a Walgreens a cumplir con la Drug Supply Chain Security Act (DSCSA) y asegurarse de que sus proveedores de medicamentos con receta estén debidamente autorizados.
La DSCSA, promulgada en 2013, tiene como objetivo mejorar la seguridad en la cadena de suministro farmacéutico y prevenir la entrada de medicamentos dañinos en el mercado. Pulse ayudará a Walgreens a verificar que solo los socios comerciales legítimos y autorizados proporcionen medicamentos a sus pacientes.
John Colaizzi, VP de práctica farmacéutica en Walgreens, enfatizó el compromiso de la empresa con la seguridad del paciente. NABP inicialmente está lanzando Pulse a usuarios selectos de la cadena de suministro, con planes de ofrecer registro gratuito a todos los miembros de la cadena de suministro de medicamentos con receta para facilitar la interoperabilidad requerida por la DSCSA.
월그린스(WBA)는 환자를 위조 약물로부터 보호하고 약물 공급망의 가시성을 향상시키기 위해 설계된 디지털 플랫폼인 NABP™의 Pulse에 합류했습니다. 이번 조치는 월그린스가 약물 공급망 보안법(DSCSA) 준수를 돕고, 처방약 공급업체가 적절히 라이센스가 있는지 확인할 것입니다.
2013년에 제정된 DSCSA는 제약 공급망의 안전성을 개선하고 유해한 약물이 시장에 유입되는 것을 방지하는 것을 목표로 합니다. Pulse는 월그린스가 오직 합법적이고 허가받은 거래 파트너만이 환자에게 약을 제공하도록 확인하는 데 도움을 줄 것입니다.
월그린스의 약제학 관행 부사장인 존 콜리지(John Colaizzi)는 환자 안전에 대한 회사의 헌신을 강조했습니다. NABP는 초기 단계에서 선택된 공급망 사용자에게 Pulse를 배포하고 있으며, DSCSA 요구 사항을 충족하기 위해 모든 처방약 공급망 구성원에게 무료 등록을 제공할 계획입니다.
Walgreens (WBA) a rejoint Pulse by NABP™, une plateforme numérique conçue pour améliorer la visibilité dans la chaîne d'approvisionnement en médicaments et protéger les patients contre les médicaments contrefaits. Cette initiative aidera Walgreens à assurer la conformité avec la Drug Supply Chain Security Act (DSCSA) et à s'assurer que ses fournisseurs de médicaments sur ordonnance sont correctement licenciés.
La DSCSA, promulguée en 2013, vise à améliorer la sécurité de la chaîne d'approvisionnement pharmaceutique et à empêcher l'entrée de médicaments nocifs sur le marché. Pulse aidera Walgreens à vérifier que seuls des partenaires commerciaux légitimes et autorisés fournissent des médicaments à ses patients.
John Colaizzi, VP de la pratique pharmaceutique chez Walgreens, a souligné l'engagement de l'entreprise envers la sécurité des patients. NABP déploie initialement Pulse auprès d'utilisateurs sélectionnés de la chaîne d'approvisionnement, avec des plans offrant une inscription gratuite à tous les membres de la chaîne d'approvisionnement des médicaments sur ordonnance pour faciliter l'interopérabilité requise par la DSCSA.
Walgreens (WBA) hat sich Pulse by NABP™ angeschlossen, einer digitalen Plattform, die entwickelt wurde, um die Sichtbarkeit in der Arzneimittelversorgungskette zu verbessern und Patienten vor gefälschten Medikamenten zu schützen. Dieser Schritt wird Walgreens bei der Konformität mit dem Drug Supply Chain Security Act (DSCSA) unterstützen und sicherstellen, dass seine verschreibungspflichtigen Medikamentenlieferanten ordnungsgemäß lizenziert sind.
Der DSCSA, der 2013 in Kraft trat, zielt darauf ab, die Sicherheit der pharmazeutischen Lieferkette zu verbessern und den Eintritt schädlicher Medikamente in den Markt zu verhindern. Pulse wird Walgreens dabei helfen, zu überprüfen, dass nur legitime und autorisierte Handelspartner Medikamente an seine Patienten liefern.
John Colaizzi, VP für Apothekenpraxis bei Walgreens, betonte das Engagement des Unternehmens für die Sicherheit der Patienten. NABP bringt Pulse zunächst bei ausgewählten Nutzern der Lieferkette auf den Markt und plant, allen Mitgliedern der Lieferkette für verschreibungspflichtige Medikamente eine kostenlose Registrierung anzubieten, um die erforderliche Interoperabilität gemäß DSCSA zu erleichtern.
- Walgreens joining Pulse platform enhances drug supply chain security
- Assists with DSCSA compliance, potentially reducing regulatory risks
- Helps ensure prescription medication suppliers are properly licensed
- Strengthens protection against counterfeit medications reaching patients
- None.
DSCSA is a federal law that was enacted in 2013 to improve the safety of the pharmaceutical supply chain and to help prevent harmful drugs from entering the market. The law requires all members of the pharmaceutical supply chain to ensure they are doing business with trading partners that are authorized in accordance with federal law.
Pulse will help ensure that only legitimate and authorized trading partners can provide medications to Walgreens' patients.
"Walgreens is committed to protecting the health and safety of our patients," said John Colaizzi, PharmD, FNJPhA, vice president of pharmacy practice at Walgreens. "Joining Pulse will be an additional DSCSA compliance tool that will help Walgreens ensure that the medications our patients take are legitimate."
"We are pleased to welcome Walgreens to Pulse," said Lemrey "Al" Carter, PharmD, MS, RPh, executive director/secretary of NABP. "Walgreens' participation in Pulse will help to strengthen the security of the pharmaceutical supply chain and help protect Walgreens' patients."
NABP is rolling out the Pulse platform to certain users in the supply chain. After this initial onboarding, NABP will provide free registration on the Pulse platform for any member of the prescription drug supply chain to facilitate interoperability, as required by DSCSA.
Learn more about Pulse and DSCSA compliance at https://pulse.pharmacy.
About NABP
NABP is the independent, international, and impartial 501(c)(3) nonprofit Association that assists its state member boards and jurisdictions in protecting the public health. NABP was established in 1904 to assist the state boards of pharmacy in creating uniform education and licensure standards. Today, we help support patient and prescription drug safety through examinations that assess pharmacist competency, pharmacist licensure transfer and verification services, and various pharmacy accreditation and inspection programs.
About Walgreens
Walgreens (www.walgreens.com) is included in the
Media Contact: media@nabp.pharmacy
View original content to download multimedia:https://www.prnewswire.com/news-releases/nabp-announces-walgreens-joining-pulse-platform-302243834.html
SOURCE National Association of Boards of Pharmacy
FAQ
What is Pulse by NABP and how does it affect Walgreens (WBA)?
How does Walgreens' (WBA) participation in Pulse impact patient safety?
What is the Drug Supply Chain Security Act (DSCSA) and how does it relate to Walgreens (WBA)?
When will NABP make Pulse available to all prescription drug supply chain members?
